AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.26%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.73% | 12.70% | 19.41% | 34.18% | 42.36% |
| Total Depreciation and Amortization | 32.54% | 86.59% | 92.68% | 106.25% | 119.13% |
| Total Amortization of Deferred Charges | 1,090.32% | 67.12% | 22.59% | -40.52% | -88.52% |
| Total Other Non-Cash Items | 123.14% | 65.61% | 91.06% | -15.20% | -26.99% |
| Change in Net Operating Assets | -219.89% | -774.69% | -396.62% | -31.26% | 34.33% |
| Cash from Operations | -31.19% | 9.00% | 26.40% | 37.53% | 52.88% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.09% | -84.12% | -60.77% | 654.61% | 5,284.91% |
| Cash from Investing | -99.09% | -84.07% | -60.62% | 617.26% | 4,722.03% |
| Total Debt Issued | 552.74% | -- | 10.00% | -90.00% | -83.82% |
| Total Debt Repaid | -490.04% | -242.63% | -162.95% | -- | -- |
| Issuance of Common Stock | 2,660.30% | 813.98% | 761.10% | 665.94% | -35.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 482.32% | 170.78% | 121.44% | -19.20% | -38.64% |
| Cash from Financing | 984.79% | 258.25% | 61.20% | 56.75% | -61.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 406.17% | 305.17% | 134.35% | 109.98% | 82.40% |